Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Edesa Biotech, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 22 | 20 | −2 |
| Shares | 2.01M | 2.05M | +41.6K (+2.1%) |
| Value | $1.63M | $1.26M | −$366.7K (−22.5%) |
New holders (1)
Institutions that held Edesa Biotech, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 200 | $126 | 0.00% |
Sold out (3)
Institutions that held Edesa Biotech, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Two Sigma Investments, LP | 11,571 | $9.38K |
| Dimensional Fund Advisors LP | 11,053 | $8.84K |
| Credit Agricole S A | 9 | $7 |